What is the recommended dose of metronidazole (Flagyl) for bacterial vaginosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Dosing for Bacterial Vaginosis

The recommended dose of metronidazole for bacterial vaginosis in non-pregnant women is 500 mg orally twice daily for 7 days. 1, 2

Standard Treatment Regimens

First-Line Oral Therapy

  • Metronidazole 500 mg orally twice daily for 7 days is the CDC-recommended standard treatment, achieving cure rates of approximately 78% and providing systemic coverage for potential subclinical upper tract infection 2, 3
  • This 7-day regimen is superior to single-dose therapy in terms of sustained cure rates 2

Alternative Oral Regimen

  • Metronidazole 2 g orally as a single dose is an alternative option, though it has lower efficacy compared to the 7-day course 2
  • The single-dose regimen may be associated with higher relapse rates and should be reserved for situations where adherence to multi-day therapy is unlikely 4

Topical Alternatives

  • Metronidazole gel 0.75%, one full applicator (5 g) intravaginally once daily for 5 days, is an effective alternative that minimizes systemic side effects 2
  • The vaginal gel achieves less than 2% of the blood levels compared to oral medication, avoiding gastrointestinal upset and metallic taste while maintaining local efficacy 1, 2

Critical Safety Warning

Patients must completely avoid all alcoholic beverages during metronidazole treatment and for at least 24 hours after the last dose to prevent severe disulfiram-like reactions. 1, 2

Special Population Dosing

Pregnant Women

  • For pregnant women, metronidazole 250 mg orally three times daily for 7 days is the recommended regimen, using a lower dose to minimize fetal exposure while providing systemic coverage 1, 2, 5
  • Metronidazole is contraindicated in the first trimester of pregnancy; clindamycin vaginal cream should be used instead during this period 2
  • Alternative regimens for pregnant women include metronidazole 2 g single dose or clindamycin 300 mg orally twice daily for 7 days 1

HIV-Infected Patients

  • Use the same treatment regimens as for HIV-negative patients, including metronidazole 500 mg orally twice daily for 7 days 1

Common Pitfalls to Avoid

  • Do not use metronidazole gel for trichomoniasis (efficacy <50%), as it is only effective for bacterial vaginosis 6
  • Avoid self-treatment with over-the-counter products, as they are ineffective for bacterial vaginosis 1
  • Sexual partners do not require treatment, as multiple clinical trials demonstrate that treating partners does not improve cure rates or prevent recurrence 1, 2

Expected Side Effects

  • Mild gastrointestinal upset and unpleasant metallic taste are common with oral metronidazole 1
  • Topical gel formulations avoid these systemic side effects while maintaining efficacy 1, 2

Follow-Up Considerations

  • No follow-up visit is necessary if symptoms completely resolve 1, 2
  • Recurrence is common, with up to 50% of women experiencing bacterial vaginosis again within one year 1
  • If symptoms return, retreatment with a recommended regimen is appropriate 1

References

Guideline

Bacterial Vaginosis Treatment with Metronidazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bacterial Vaginosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bacterial vaginosis.

Primary care update for Ob/Gyns, 2000

Research

Treatment of sexually transmitted vaginosis/vaginitis.

Reviews of infectious diseases, 1990

Research

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.